Month: November 2024

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia – Yahoo Finance

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia  Yahoo...

Read More

Recent Comments

No comments to show.

Discover the most outstanding Educational articles on all topics of life. Write your stories and share them with us

Discover the most outstanding articles on all topics of life. Write your stories and share them

Recent Comments